Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. Pexiganan (Locilex) for mild foot infection in diabetic foot ulcers. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2016 Authors' objectives Diabetes is a common life-long condition. People with diabetes have very high levels of glucose, a type of sugar, in their blood because their bodies do not make enough insulin or the insulin does not work properly. Diabetes can cause foot problems, such as infections and ulcers. Some people may have their feet amputated if the ulcer or infection is severe.
Pexiganan is a new antibiotic cream for diabetic foot ulcers. Some studies have suggested that pexiganan can treat mild infections in patients with diabetic foot ulcers. More studies are trying to show how well pexiganan works and whether it is safe to use.
If pexiganan is licenced for use in the UK, it could be a new treatment option for patients with diabetic foot ulcers. Indexing Status Subject indexing assigned by CRD MeSH Antimicrobial Cationic Peptides; Diabetic Foot; Focal Infection; Humans; Ulcer Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Research&Intelligence Centre, University of Birmingham, Institute of Applied Health Research, Public Health building, Edgbaston, Birmingham B15 2TT
Tel: 0121 414 9077 Email: nihrhsc@contacts.bham.ac.uk AccessionNumber 32016000442 Date abstract record published 08/03/2016 |